Analysis of human prostate cancer samples revealed that 85 of 112 tumors exhibited TLR3 expression, and elevated TLR3 levels were significantly correlated with an increased risk of cancer recurrence (37). This evidence concerns the gene TLR3 and prostate carcinoma.